India’s First Artificial Liver Tissue
A Bengaluru-based biotech start-up, Pandorum Technologies, has become the first Indian firm to develop artificial living tissue, which performs the function of a human liver, and can lead to affordable, full-scale transplantable organs in few a years. These 3D printed tissues, with reduced animal and human trials, would also make it possible to develop new medicines and vaccines.
• Pandorum Technologies Pvt. Ltd, a biotechnology start-up focused on tissue engineering, has made India’s first artificial human liver tissue with the help of 3D printing technology. Pandorum was founded in 2011 to make artificial human organs on demand.
• The tissue performs critical functions of a human liver tissue including detoxification, metabolism and secretion of biochemicals such as albumin and cholesterol.The tissue can grow and survive up to eight weeks.
• To build liver tissue of 5 mm size Pandorum needed 10 million liver cells, which were arranged in three-dimensional architecture, a bio-material made up of glucose, proteins and living cells extracted from a particular type of insect is used as ink, which is placed in three interchangeable dispensers of the printer’s head controlled by lasers. Pandorum sourced a million liver cells from a bio-bank and multiplied them in its laboratory.
• 3D printing technology has the potential to save lives of patients with liver failure. While the current 3D printing technology is able to make small slices of tissue, producing a complete organ such as the liver with 300 billion cells may take several years. As of today, 3D printed living tissues are used for testing drugs in the early-development phase.
• Liver toxicity and drug metabolism are the key hurdles, and contributors to failed human trials. 3D bio-printed mini-livers that mimic the human liver will serve as test platforms for discovery and development of drugs with better efficacy, less side-effects and at lower costs.
• Pandorum is funded by the Department of Biotechnology and incubated at the Centre for Cellular and Molecular Platforms, Bangalore Bio-Cluster
• Development of artificial organs has numerous clinical uses. Cell based organoids can be used to develop bio-artificial liver support systems for preserving life in patients who have developed liver failure. In the near future, such bio-printed organs will address the acute shortage of human organs available for surgical transplantation,” said Bhowmick, who holds a PhD from the Indian Institute of Science.
• In India, thousands of lives are lost every year because of unavailability of organs. More than 75,000 livers, 200,000 kidneys and 50,000 hearts are needed in hospitals across the country. The current availability through organ donation and cadaver transplants is around 1,500 livers, 7, 50 hearts.

